Topical Antibiotic Ointment for Uncomplicated Bacterial Conjunctivitis
For an adult or older child with uncomplicated bacterial conjunctivitis and no macrolide allergy, contact-lens wear, or recent ocular surgery, prescribe erythromycin 0.5% ophthalmic ointment applied to the lower conjunctival sac 2–3 times daily for 5–7 days. 1
Why Erythromycin Ointment Is the Preferred Choice
Erythromycin ointment provides bactericidal activity against the three most common bacterial pathogens (Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae) that cause uncomplicated conjunctivitis. 2
No single topical antibiotic has demonstrated superiority over others for uncomplicated bacterial conjunctivitis, allowing selection based on dosing convenience, cost, and local resistance patterns. 1
Erythromycin ointment is widely available, inexpensive, and has a well-documented safety profile across all age groups, including pregnant women and children. 2
The ointment formulation is particularly useful for bedtime application because it provides prolonged contact time with the ocular surface, though it has more limited corneal penetration than solutions. 3
Alternative Topical Options When Erythromycin Is Unavailable
Polymyxin B-bacitracin ointment is an effective alternative that shortens the duration of clinical disease and enhances bacterial eradication from the conjunctiva. 4
Trimethoprim-polymyxin B solution has been found safe and effective for treating bacterial conjunctivitis, with clinical cure rates of 47% by days 3–6 and 84% by 2–7 days after completion of therapy. 5
Gentamicin ophthalmic solution can be considered as a second-line option, with similar efficacy to other topical agents (49% cure rate by days 3–6,88% by 2–7 days post-therapy). 5
Expected Clinical Course and Follow-Up
Topical antibiotics provide earlier clinical and microbiological remission (68.2% cure rate versus 55.5% with placebo by days 4–9), allowing faster return to work or school. 1, 6
Instruct the patient to return for evaluation in 3–4 days if no improvement occurs, as lack of response may indicate resistant organisms, viral infection, or an alternative diagnosis. 1, 3
Approximately 64% of mild bacterial conjunctivitis cases resolve spontaneously by days 6–10 without treatment, but antibiotics shorten symptom duration and reduce transmissibility. 1, 6
Critical Red Flags Requiring Immediate Ophthalmology Referral
Do not prescribe topical antibiotics and arrange urgent ophthalmology evaluation if any of the following are present:
- Visual loss or significant change in vision 1
- Moderate to severe eye pain (beyond mild irritation) 1
- Corneal involvement (opacity, infiltrate, or ulcer on examination) 1
- Severe purulent discharge suggesting possible gonococcal infection 1
- History of herpes simplex virus eye disease 1
- Immunocompromised state 1
- Lack of clinical response after 3–4 days of appropriate therapy 1
Special Populations Requiring Different Management
Contact-Lens Wearers
Reserve fluoroquinolones (ofloxacin or ciprofloxacin) for contact-lens wearers because of the higher risk of Pseudomonas infection requiring more aggressive coverage. 1
Do not use erythromycin or polymyxin B-bacitracin in contact-lens wearers with purulent conjunctivitis due to inadequate Pseudomonas coverage. 3
Suspected Gonococcal or Chlamydial Conjunctivitis
Topical antibiotics alone are insufficient; these infections require mandatory systemic therapy with ceftriaxone 250 mg IM plus azithromycin 1 g orally for gonorrhea, or azithromycin 1 g orally (or doxycycline 100 mg twice daily for 7 days) for chlamydia. 1
Obtain conjunctival cultures and Gram staining before initiating systemic antibiotics if gonococcal infection is suspected. 1
Daily ophthalmologic monitoring is required until complete resolution to prevent corneal perforation, which can occur within 24 hours of symptom onset in untreated gonococcal disease. 1
Pregnant Patients
Erythromycin 0.5% ophthalmic ointment is the first-line agent in pregnancy due to its well-documented fetal safety record. 2
Topical fluoroquinolones (moxifloxacin, ofloxacin) should be avoided in pregnancy because they are classified as potentially fetotoxic. 2
For systemic therapy of gonococcal or chlamydial conjunctivitis in pregnancy, use ceftriaxone 250 mg IM plus azithromycin 1 g orally; never use doxycycline, quinolones, or tetracyclines. 2
Common Pitfalls to Avoid
Do not prescribe antibiotic-steroid combination drops (e.g., Tobradex) without first definitively excluding viral conjunctivitis, particularly herpes simplex virus, because steroids can exacerbate viral replication and worsen outcomes. 1, 2
Do not use topical antibiotics for viral conjunctivitis, as they provide no clinical benefit and increase the risk of toxicity and antimicrobial resistance. 1, 7
Do not prescribe oral antibiotics for routine bacterial conjunctivitis; systemic therapy is reserved exclusively for gonococcal and chlamydial infections. 1
Avoid prolonged use of topical antibiotics beyond 7 days unless a specific indication exists, as extended use is associated with ocular toxicity. 1
Infection Control Measures
Strict hand hygiene with soap and water is crucial to prevent transmission of bacterial conjunctivitis. 1
Patients should avoid close contact for 7–14 days from symptom onset in viral conjunctivitis to reduce transmission risk. 1
Discard multiple-dose eyedrop containers to avoid cross-contamination. 1